MSMB gene variant alters the association between prostate cancer and number of sexual partners

Prostate

Volumn 73, Issue 16, 2013, Pages 1803-1809

  Stott Miller, Marni ^a   Wright, Jonathan L ^a,b   Stanford, Janet L ^a,c  

^a USA   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

MSMB; prostate cancer; PSP94; rs10993994; sexual partners; sexually transmitted infections

Indexed keywords

BETA MICROSEMINOPROTEIN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILY HISTORY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; SINGLE NUCLEOTIDE POLYMORPHISM;

MSMB; PROSTATE CANCER; PSP94; RS10993994; SEXUAL PARTNERS; SEXUALLY TRANSMITTED INFECTIONS;

ADULT; AGED; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; PROSTATIC SECRETORY PROTEINS; RISK FACTORS; SEXUAL PARTNERS; SEXUALLY TRANSMITTED DISEASES;

EID: 84886952681     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22719     Document Type: Article

References (29)

1. Nam RK, Reeves JR, Toi A, Dulude H, Trachtenberg J, Emami M, Daigneault L, Panchal C, Sugar L, Jewett MA, Narod SA,. A novel serum marker, total prostate secretory protein of 94 amino acids, improves prostate cancer detection and helps identify high grade cancers at diagnosis. J Urol 2006; 175 (4): 1291-1297.
2. Tsurusaki T, Koji T, Sakai H, Kanetake H, Nakane PK, Saito Y,. Cellular expression of beta-microseminoprotein (beta-MSP) mRNA and its protein in untreated prostate cancer. Prostate 1998; 35 (2): 109-116.
3. Chan PS, Chan LW, Xuan JW, Chin JL, Choi HL, Chan FL,. In situ hybridization study of PSP94 (prostatic secretory protein of 94 amino acids) expression in human prostates. Prostate 1999; 41 (2): 99-109. Epub 1999/09/09.
4. Imasato Y, Xuan JW, Sakai H, Izawa JI, Saito Y, Chin JL, Moussa M,. PSP94 expression after androgen deprivation therapy: A comparative study with prostate specific antigen in benign prostate and prostate cancer. J Urol 2000; 164 (5): 1819-1824.
5. Whitaker HC, Warren AY, Eeles R, Kote-Jarai Z, Neal DE,. The potential value of microseminoprotein-beta as a prostate cancer biomarker and therapeutic target. Prostate 2010; 70 (3): 333-340.
6. FitzGerald LM, Zhang X, Kolb S, Kwon EM, Liew YC, Hurtado-Coll A, Knudsen BS, Ostrander EA, Stanford JL,. Investigation of the relationship between prostate cancer and MSMB and NCOA4 genetic variants and protein expression. Hum Mutat 2013; 34 (1): 149-156.
7. Eeles RA, Kote-Jarai Z, Giles GG, Olama AA, Guy M, Jugurnauth SK, Mulholland S, Leongamornlert DA, Edwards SM, Morrison J, Field HI, Southey MC, Severi G, Donovan JL, Hamdy FC, Dearnaley DP, Muir KR, Smith C, Bagnato M, Ardern-Jones AT, Hall AL, O'Brien LT, Gehr-Swain BN, Wilkinson RA, Cox A, Lewis S, Brown PM, Jhavar SG, Tymrakiewicz M, Lophatananon A, Bryant SL, UK Genetic Prostate Cancer Study Collaborators, British Association of Urological Surgeons' Section of Oncology, UK ProtecT Study Collaborators, Horwich A, Huddart RA, Khoo VS, Parker CC, Woodhouse CJ, Thompson A, Christmas T, Ogden C, Fisher C, Jamieson C, Cooper CS, English DR, Hopper JL, Neal DE, Easton DF,. Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet 2008; 40 (3): 316-321.
8. Thomas G, Jacobs KB, Yeager M, Kraft P, Wacholder S, Orr N, Yu K, Chatterjee N, Welch R, Hutchinson A, Crenshaw A, Cancel-Tassin G, Staats BJ, Wang Z, Gonzalez-Bosquet J, Fang J, Deng X, Berndt SI, Calle EE, Feigelson HS, Thun MJ, Rodriguez C, Albanes D, Virtamo J, Weinstein S, Schumacher FR, Giovannucci E, Willett WC, Cussenot O, Valeri A, Andriole GL, Crawford ED, Tucker M, Gerhard DS, Fraumeni JF Jr, Hoover R, Hayes RB, Hunter DJ, Chanock SJ,. Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet 2008; 40 (3): 310-315.
9. Chang BL, Cramer SD, Wiklund F, Isaacs SD, Stevens VL, Sun J, Smith S, Pruett K, Romero LM, Wiley KE, Kim ST, Zhu Y, Zhang Z, Hsu FC, Turner AR, Adolfsson J, Liu W, Kim JW, Duggan D, Carpten J, Zheng SL, Rodriguez C, Isaacs WB, Grönberg H, Xu J,. Fine mapping association study and functional analysis implicate a SNP in MSMB at 10q11 as a causal variant for prostate cancer risk. Hum Mol Genet 2009; 18 (7): 1368-1375.
10. Lou H, Yeager M, Li H, Bosquet JG, Hayes RB, Orr N, Yu K, Hutchinson A, Jacobs KB, Kraft P, Wacholder S, Chatterjee N, Feigelson HS, Thun MJ, Diver WR, Albanes D, Virtamo J, Weinstein S, Ma J, Gaziano JM, Stampfer M, Schumacher FR, Giovannucci E, Cancel-Tassin G, Cussenot O, Valeri A, Andriole GL, Crawford ED, Anderson SK, Tucker M, Hoover RN, Fraumeni JF Jr, Thomas G, Hunter DJ, Dean M, Chanock SJ,. Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility. Proc Natl Acad Sci USA 2009; 106 (19): 7933-7938.
11. Whitaker HC, Kote-Jarai Z, Ross-Adams H, Warren AY, Burge J, George A, Bancroft E, Jhavar S, Leongamornlert D, Tymrakiewicz M, Saunders E, Page E, Mitra A, Mitchell G, Lindeman GJ, Evans DG, Blanco I, Mercer C, Rubinstein WS, Clowes V, Douglas F, Hodgson S, Walker L, Donaldson A, Izatt L, Dorkins H, Male A, Tucker K, Stapleton A, Lam J, Kirk J, Lilja H, Easton D,. IMPACT Study Steering Committee. IMPACT Study Collaborators. UK GPCS Collaborators., Cooper C, Eeles R, Neal DE,. The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine. PLoS ONE 2010; 5 (10): e13363.
12. Laurence M,. PSP94, what is it good for? [monograph]. Montreal, Canada; 2012.
13. Sutcliffe S, Zenilman JM, Ghanem KG, Jadack RA, Sokoll LJ,. Sexually transmitted infections and prostatic inflammation/cell damage as measured by serum prostate specific antigen concentration. J Urol 2006; 175: 1937-1942.
14. Taylor ML, Mainous AG III, Wells BJ,. Prostate cancer and sexually transmitted diseases: A meta-analysis. Family Med 2005; 37 (7): 506-512.
15. Dennis LK, Dawson DV,. Meta-analysis of measures of sexual activity and prostate cancer. Epidemiology 2002; 13: 72-79.
16. Rosenblatt KA, Wicklund KG, Stanford JL,. Sexual factors and the risk of prostate cancer. Am J Epidemiol 2001; 153 (12): 1152-1158.
17. Agalliu I, Salinas CA, Hansten PD, Ostrander EA, Stanford JL,. Statin use and risk of prostate cancer: Results from a population-based epidemiologic study. Am J Epidemiol 2008; 168 (3): 250-260.
18. Stanford JL, Wicklund KG, McKnight B, Daling JR, Brawer MK,. Vasectomy and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 1999; 8 (10): 881-886.
19. Cook LS, Koutsky LA, Holmes KK,. Circumcision and sexually transmitted diseases. Am J Public Health 1994; 84 (2): 197-201.
20. Diseker RA III, Peterman TA, Kamb ML, Kent C, Zenilman JM, Douglas JM Jr, Rhodes F, Iatesta M,. Circumcision and STD in the United States: Cross sectional and cohort analyses. Sex Transm Infect 2000; 76 (6): 474-479.
21. Wright JL, Lin DW, Stanford JL,. Circumcision and the risk of prostate cancer. Cancer 2012; 118 (18): 4437-4443.
22. Koutsky L,. Epidemiology of genital human papillomavirus infection. Am J Med 1997; 102 (5A): 3-8.
23. Myers ER, McCrory DC, Nanda K, Bastian L, Matchar DB,. Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. Am J Epidemiol 2000; 151 (12): 1158-1171.
24. De Marzo AM, Platz EA, Sutcliffe S, Xu J, Grönberg H, Drake CG, Nakai Y, Isaacs WB, Nelson WG,. Inflammation in prostate carcinogenesis. Nat Rev Cancer 2007; 7 (4): 256-269.
25. Martinez-Fierro ML, Leach RJ, Gomez-Guerra LS, Garza-Guajardo R, Johnson-Pais T, Beuten J, Morales-Rodriguez IB, Hernandez-Ordoñez MA, Calderon-Cardenas G, Ortiz-Lopez R, Rivas-Estilla AM, Ancer-Rodriguez J, Rojas-Martinez A,. Identification of viral infections in the prostate and evaluation of their association with cancer. BMC cancer 2010; 10: 326.
26. Sutcliffe S, Giovannucci E, Alderete JF, Chang TH, Gaydos CA, Zenilman JM, De Marzo AM, Willett WC, Platz EA,. Plasma antibodies against Trichomonas vaginalis and subsequent risk of prostate cancer. Cancer epidemiology. Biomarkers Prev 2006; 15 (5): 939-945.
27. Edström Hägerwall AM, Rydengård V, Fernlund P, Mörgelin M, Baumgarten M, Cole AM, Malmsten M, Kragelund BB, Sørensen OE,. beta-Microseminoprotein endows post coital seminal plasma with potent candidacidal activity by a calcium- and pH-dependent mechanism. PLoS Pathogens 2012; 8 (4): e1002625.
28. Hunter DJ,. Gene-environment interactions in human diseases. Nat Rev Genet 2005; 6 (4): 287-298.
29. Garcia-Closas M, Thompson WD, Robins JM,. Differential misclassification and the assessment of gene-environment interactions in case-control studies. Am J Epidemiol 1998; 147 (5): 426-433.